MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Market By Drugs & Devices And Geography | Forecast 2019- 2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report on the Middle East and African ophthalmology drugs and devices market estimates the market to upsurge with a CAGR of 6.89% in the forecasting years of 2019-2027.

The report on the Middle East and Africa’s ophthalmology drugs and devices market includes the countries of:

•           The United Arab Emirates

•           Saudi Arabia

•           Turkey

•           South Africa

•           Rest of the Middle East & Africa

Report scope can be customized per your requirements. Request For Customization

The Middle East and Africa ophthalmological drugs and devices market is mainly driven owing to the initiatives taken by the private organizations in the United Arab Emirates, along with high healthcare expenditure in the underdeveloped African countries which includes Rwanda, Uganda and Malawi. The United Arab Emirates government has taken initiatives to enhance the ophthalmological medical services in the country, which includes the establishment of eye specialty hospitals, specifically in the urban and semi-urban provinces of the country. According to company sources, Moorefield’s, which is a UK-based healthcare center, has launched Moorefield’s Eye Hospital Center in the city of Abu Dhabi in cooperation with UE Medical, a UAE-based organization that aims to offer efficient & cost-effective ophthalmological medical services to the individuals of the country. The Moorefield’s eye hospital would be accompanying a team of expert ophthalmologists, who precisely focus on medical retinal diseases, such as diabetic retinopathy, which has a high prevalence in the country.

The demand for intraocular lenses and phacoemulsification devices is rising as a result of the increasing prevalence of cataracts. As per the WHO, unoperated cataracts and uncorrected refractive errors are the top two causes of vision impairment. Increasing incidences of ocular and ophthalmic conditions are the major factor driving the demand for intraocular lenses and phacoemulsification devices, as intraocular lens are planted in humans when the natural lens is surgically removed due to cataract, and phacoemulsification devices are required to perform cataract surgeries. Furthermore, various governments across the globe are also providing incentives on the cataract surgeries, further providing plenty of growth opportunities for the ophthalmology drug and devices market.

Allergan, Inc. is an Irish pharmaceutical company, that develops, manufactures, markets and distributes specialty-branded, biosimilar and OTC products. The company operates in several countries around the world, including the US, Canada, China, India and other high growth markets of Europe, Southeast Asia, the Middle East and Latin America.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1.               BARGAINING POWER OF BUYERS

2.2.2.               BARGAINING POWER OF SUPPLIER

2.2.3.               THREATS OF NEW ENTRANTS

2.2.4.               THREATS OF SUBSTITUTES

2.2.5.               COMPETITIVE RIVALRY

2.3. STRATEGIC OUTLOOK

2.4. KEY INSIGHT

2.5. VALUE CHAIN OUTLOOK

2.6. KEY BUYING STANDARDS

2.7. INVESTMENT OUTLOOK

2.8. SUPPLY CHAIN OUTLOOK

2.9. MARKET DRIVERS

2.9.1.               INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR

2.9.2.               UPSURGE IN HEALTHCARE SPENDING

2.9.3.               TECHNOLOGICAL ADVANCEMENT

2.10.            MARKET RESTRAINTS

2.10.1.            EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY

2.10.2.            LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS

2.10.3.            DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE

2.11.            MARKET OPPORTUNITIES

2.11.1.            DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES IS INCREASING

2.12.            MARKET CHALLENGES

2.12.1.            DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES

3.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES

3.1. DEVICES

3.1.1.               DIAGNOSTIC & MONITORING EQUIPMENT

3.1.1.1.      OPTICAL COHERENCE TOMOGRAPHY

3.1.1.2.      OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

3.1.1.3.      FUNDUS CAMERA MARKET

3.1.1.4.      OPHTHALMOSCOPES

3.1.1.5.      RETINOSCOPE

3.1.1.6.      PACHYMETER

3.1.1.7.      WAVEFRONT ABERROMETERS

3.1.1.8.      PERIMETERS/VISUAL FIELD ANALYZER

3.1.1.9.      AUTOREFRACTORS/PHOROPTER

3.1.1.10.   SPECULAR MICROSCOPE

3.1.1.11.   CORNEAL TOPOGRAPHERS

3.1.1.12.   OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET

3.1.2.               SURGERY DEVICES

3.1.2.1.      CATARACT SURGERY DEVICES

3.1.2.2.      GLAUCOMA SURGERY DEVICES

3.1.2.3.      REFRACTIVE SURGERY DEVICES

3.1.2.4.      VITREORETINAL SURGERY DEVICES

3.1.3.               VISION CARE

3.2. DRUGS

3.2.1.               GLAUCOMA DRUG

3.2.2.               RETINAL DISORDER DRUG

3.2.3.               DRY EYE DRUG

3.2.4.               ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

3.2.5.               DRUGS BY USE OF PRESERVATION

3.2.5.1.      PRESERVED DRUGS

3.2.5.2.      PRESERVATIVE-FREE DRUGS

4.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK

4.1.1.               UNITED ARAB EMIRATES

4.1.2.               SAUDI ARABIA

4.1.3.               TURKEY

4.1.4.               SOUTH AFRICA

4.1.5.               REST OF MIDDLE EAST & AFRICA

5.    COMPETITIVE LANDSCAPE

5.1. ALLERGAN, INC.

5.2. BAYER

5.3. CARL ZEISS AG

5.4. ESSILOR INTERNATIONAL S.A.

5.5. GLAXOSMITHKLINE

5.6. JOHNSON & JOHNSON, INC.

5.7. NOVARTIS INTERNATIONAL AG

5.8. PFIZER

5.9. ROCHE HOLDING AG

5.10.            SANTEN PHARMACEUTICAL CO., LTD.

6.    METHODOLOGY AND SCOPE

6.1. RESEARCH SCOPE

6.2. SOURCES OF DATA

6.3. RESEARCH METHODOLOGY

List of table

TABLE 1        MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 2        COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

TABLE 3        SELECTED LISTS OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

TABLE 4        MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 5        MIDDLE EAST AND AFRICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT  BY TYPES 2019-2027 ($ MILLION)

TABLE 6        MIDDLE EAST AND AFRICA DEVICES MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)

TABLE 7        MIDDLE EAST AND AFRICA DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)

TABLE 8        MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

FIGURE 2      MIDDLE EAST AND AFRICA DRUGS AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)

FIGURE 3      MIDDLE EAST AND AFRICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 4      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($ MILLION)

FIGURE 5      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)

FIGURE 10   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027 ($ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2019-2027 ($ MILLION)

FIGURE 16   MIDDLE EAST AND AFRICA DEVICES MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 18   MIDDLE EAST AND AFRICA SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 19   MIDDLE EAST AND AFRICA SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 21   MIDDLE EAST AND AFRICA DEVICES MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)

FIGURE 22   MIDDLE EAST AND AFRICA DRUGS AND DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)

FIGURE 23   MIDDLE EAST AND AFRICA DRUGS MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)

FIGURE 24   MIDDLE EAST AND AFRICA DRUGS MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)

FIGURE 25   MIDDLE EAST AND AFRICA DRUGS MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION)

FIGURE 26   MIDDLE EAST AND AFRICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($ MILLION)

FIGURE 27   MIDDLE EAST AND AFRICA DRUGS BY USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)

FIGURE 28   MIDDLE EAST AND AFRICA DRUGS BY USE OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)

FIGURE 29   MIDDLE EAST AND AFRICA PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)

FIGURE 30   MIDDLE EAST AND AFRICA PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)

FIGURE 31   SAUDI ARABIA COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 32   TURKEY COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 33   UNITED ARAB EMIRATES COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 34   SOUTH AFRICA COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 35   REST OF MIDDLE EAST & AFRICA COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;